"Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

End User License Agreement (for non-institutional, personal use)

2. LINKING THE EGFR WITH CANCER THERAPUTICS

4. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - LIGANDS OF THE EGFR AS PREDICTORS OF RESPONSE TO ANTI-EGFR THERAPY

5. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - ALTERATIONS IN ERBB RECEPTORS FAMILY MEMBERS

6. Alterations in Non-ErbB Receptor Family Members

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor– Part I: Extracellular Molecules

2. INTRACELLULAR TRAFFICKING OF THE egfr AND RESISTANCE TO ANTI-eGFR Therapy

3. The ras/ref/mek/erk Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

4. The PI3-K Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

5. ANALYSIS OF SEVERAL BIOMARKERS IN COMBINATION AND RESISTANCE TO ANTI-eGFR Therapy

6. The JAK/STAT Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor – Part II: Intracellular Molecules

Chemotherapeutic, Immunologic, and Molecularly Targeted Therapy for the Treatment of Advanced Melanoma

1. THERAPEUTICAL APPROACHES TO CANCER: FROM Chemotherapy to Targeted Therapies

3. THE WARBURG EFFECT: CURRENT PERSPECTIVE

4. CURRENT AND PAST EFFORTS AT TARGETING THE WARBURG EFFECT FOR CANCER THERAPY

Targeting the Warburg Effect for Cancer Therapy: A Long and Winding Road

3. Previous Considerations before Therapy

6. Novel and Emerging Pharmacological Agents

7. Innovative Immunotherapy Strategies for Treatment of FL

Immunotherapy Strategies in Follicular Lymphoma: Antibodies, Vaccines and Cells

Cancer Epigenetics AND Role in Carcinogenesis

Modulation of Metabolism by Epigenetic Dys-regulation

Epigenetic Regulation by the Availability of Co-substrates

Epigenetic Dysregulation Induced by Oncometabolites

Epigenetics and Cancer Cell Metabolism: Cross-talk and Therapeutic Opportunities

Apoptosis Targeting Therapeutics in Clinical Trials

Bentham Science Publishers

"Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.
The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors.
 
Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field."


Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 3

Atta-ur-Rahman

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The second volume of this series features reviews that cover a variety of topics including: 
-Identification of nosocomial pathogens and antimicrobials using phenotypic techniques
-Topical antimicrobials
-Anti-infective drug safety
-Antimicrobial resistance
… and much more."


Frontiers in Clinical Drug Research - Anti Infectives: Volume 2

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents the following reviews:
Recent Progress on Asymmetric Synthesis of Chiral Flavanones, Chromanones, and Chromenes
Supramolecular Chemistry of Modified Amino Acids and Short Peptides
The Use of Nanocatalysts in the Synthesis of Heterocycles: A Contemporary Approach
Synthesis and Applications of 1,2,3-Triazoles
Ring C–H Functionalization of Aromatic N-Oxides 
 "


Advances in Organic Synthesis: Volume 11

Frontiers in Natural Product Chemistry is a book series devoted to publishing monographs that highlight important advances in natural product chemistry. The series covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series.
Volume nine of the series brings together 7 reviews on a variety of natural products and sources along with a chapter on the basics of investigating antioxidant activity.
Propolis and its key chemical constituents: a promising natural product in therapeutic applications
Investigation of the effects of using omega-3 fatty acids on egg quality in functional egg production 
Quercetin, a flavonoid with remarkable anticancer activity 
Swertiamarin for the treatment of metabolic syndrome
Overview of traditional uses, phytochemistry and pharmacology of Peganum harmala l. 
Investigation of measurement methods of antioxidant activity and involved mechanisms
Recent progress on natural and synthetic flavanone and its derivatives
Role of virgin coconut oil as a multiple health promoting function oil

Frontiers in Natural Product Chemistry: Volume 9

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
Contents of this volume include these 6 reviews:
 
- Multicomponent synthesis of heterocycles by microwave irradiation
- Stereoselective procedures for the synthesis of olefines
- Advanced microwave assisted organic synthesis method in organic chemistry
- Five and six-membered n-heterocycle rings from diaminomaleonitrile
- Peptidomimetics: current and future perspectives on hiv protease inhibitors
- A review on synthesis, chemistry, and medicinal properties of benzothiazines and their related scaffolds"


Advances in Organic Synthesis: Volume 17

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eighth volume of the series features chapters covering the following topics:
- T cells in gastrointestinal cancers
- The pharmacology of adjudin – a male contraceptive with anti-cancer properties
- Manipulating the tumor microenvironment
- Treatment of hepatocellular carcinoma
- Gold-based compounds as potential anti-cancer drug candidates
- Oral nanostructure drug delivery for anti-cancer treatment"


Frontiers in Anti-Cancer Drug Discovery: Volume 8

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
 
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.
 
 
 
The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:
 
- Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
 
- The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
 
- Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
 
- Use of Antipsychotics in Patients with Alzheimer’s Disease
 
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
 
- Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease"



Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

"Topics in Anti-Cancer Research covers new developments in the field of cancer. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. It also encompasses the role of estrogen as estrogen disruptor and strategies targeting cancer stem cells for the treatment of different types of cancer, including myeloma and renal cell cancer.
 
The diversity of researches and topics published in this eBook Series will be valuable to our cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers.
 
The topics covered in the Eighth Volume of this series are as follows:
 
- Novel Drugs for Multiple Myeloma
 
- Synthetic Estrogens are Endocrine Disruptors via Inhibition of AF1 Domain of ERs
 
- Recent Progress of Phenazines as Anticancer Agents
 
- Cancer Stem Cell Targeting for Anticancer Therapy: Strategies and Challenges"


Topics in Anti-Cancer Research: Volume 8

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
The sixth volume of this series features these interesting reviews:
 
- Direct-acting antiviral drugs for treatment of Hepatitis C virus infection
 
- Plant lattices as anti-infective compounds
 
- Antimicrobial materials and devices for biomedical applications
 
- Recent advances in the treatment of toxoplasmosis
 
- Antimicrobial immunoglobulin prophylaxis and therapy
 
- Targeting Magnesium Homeostasis as Potential Anti-Infective Strategy Against Mycobacteria"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 6

"Herbal Medicine: Back to the Future compiles expert reviews on the application of herbal medicines (including Ayurveda, Chinese traditional medicines and alternative therapies) to treat different ailments. The book series demonstrates the use of sophisticated methods to understand traditional medicine, while providing readers a glimpse into the future of herbal medicine.
 
This volume presents reviews of traditional Chinese medicine and other nutritional therapies useful for treating cardiovascular diseases, including: 
cardiovascular benefits of the European Olive and bottle gourd
a review of the cardiovascular benefits of Naoxintong
herbal and micronutrient supplements for cardiovascular disease patients
herbal remedies for atherosclerosis
cardio-protective alkaloids
 
This volume is essential reading for all researchers in the field of natural product chemistry and pharmacology. Medical professionals involved in cardiovascular care who seek to improve their knowledge about herbal medicine and alternative therapies will also benefit from the contents of the volume."


Votre panier

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

$ 99.00

description_of_book

Informations supplémentaires

À propos des auteurs

Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 3

Frontiers in Clinical Drug Research - Anti Infectives: Volume 2

Advances in Organic Synthesis: Volume 11

Frontiers in Natural Product Chemistry: Volume 9

Advances in Organic Synthesis: Volume 17

Frontiers in Anti-Cancer Drug Discovery: Volume 8

Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

Topics in Anti-Cancer Research: Volume 8

Frontiers in Clinical Drug Research - Anti Infectives: Volume 6

Cardiovascular Diseases

Atta-ur-Rahman